--- title: "18:00 ET\n \n \n SHAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of ALVR, IPG, AVAV, WMPN to Act Now" type: "News" locale: "en" url: "https://longbridge.com/en/news/229808901.md" description: "Monteverde & Associates PC is urging shareholders of AlloVir, Interpublic Group, AeroVironment, and William Penn Bancorporation to act regarding their proposed mergers. Shareholder votes are scheduled for March and April 2025, with specific ownership stakes outlined for each company post-merger. The firm, recognized for recovering millions for shareholders, emphasizes the importance of legal representation in class actions. Interested shareholders can contact the firm for more information." datetime: "2025-02-26T23:00:50.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/229808901.md) - [en](https://longbridge.com/en/news/229808901.md) - [zh-HK](https://longbridge.com/zh-HK/news/229808901.md) generator: "portal-rs" --- # 18:00 ET SHAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of ALVR, IPG, AVAV, WMPN to Act Now , /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a **Top 50 Firm** by ISS Securities Class Action Services Report. We are headquartered at the **Empire State Building** in New York City and are investigating: - **AlloVir, Inc. (Nasdaq: ALVR)**, relating to its proposed merger with Kalaris Therapeutics. Under the terms of the agreement, AlloVir will acquire 100% of the outstanding equity interest of Kalaris. Upon completion, pre-Merger AlloVir stockholders are expected to own approximately 25.05% of the combined company. **ACT NOW**. The Shareholder Vote is scheduled for **March 12, 2025.** **Click here for more information** https://monteverdelaw.com/case/allovir-inc-alvr/. **It is free and there is no cost or obligation to you.** - **The Interpublic Group of Companies, Inc. (NYSE: IPG)**, relating to the proposed merger with Omnicom Group Inc. Under the terms of the agreement, Interpublic shareholders will own 39.4% of the combined company. **ACT NOW**. The Shareholder Vote is scheduled for **March 18, 2025.** **Click here for more** https://monteverdelaw.com/case/interpublic-group-of-companies-inc-ipg/. **It is free and there is no cost or obligation to you.** - **AeroVironment, Inc. (Nasdaq: AVAV)**, relating to the proposed merger with BlueHalo LLC. Under the terms of the agreement, AeroVironment shareholders will own approximately 60.5% of the combined company. **ACT NOW**. The Shareholder Vote is scheduled for **April 1, 2025.** **Click here for more information** https://monteverdelaw.com/case/aerovironment-inc-avav/. **It is free and there is no cost or obligation to you.** - **William Penn Bancorporation (Nasdaq: WMPN),** relating to its proposed merger with Mid Penn Bancorp, Inc. Under the terms of the agreement, shareholders of William Penn will receive 0.4260 shares of Mid Penn common stock for each share of William Penn common stock. Additionally, all options of William Penn will be rolled into Mid Penn equivalent options. The implied transaction value is approximately $13.58 per William Penn share. **ACT NOW**. The Shareholder Vote is scheduled for **April 2, 2025.** **Click here for more information** https://monteverdelaw.com/case/william-penn-bancorporation-wmpn/. **It is free and there is no cost or obligation to you.** **NOT ALL LAW FIRMS ARE THE SAME.** Before you hire a law firm, you should talk to a lawyer and ask: 1. Do you file class actions and go to Court? 2. When was the last time you recovered money for shareholders? 3. What cases did you recover money in and how much? **About Monteverde & Associates PC** Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. **No company, director or officer is above the law.** If you own common stock in any of the above listed companies and have concerns or wish to obtain additional information free of charge, please visit our **website** or contact Juan Monteverde, Esq. either via e-mail at **\[email protected\]** or by telephone at (212) 971-1341. Contact: Juan Monteverde, Esq. MONTEVERDE & ASSOCIATES PC **The Empire State Building** 350 Fifth Ave. Suite 4740 New York, NY 10118 United States of America \[email protected\] Tel: (212) 971-1341 Attorney Advertising. (C) 2025 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter. SOURCE Monteverde & Associates PC ### Related Stocks - [ALVR.US](https://longbridge.com/en/quote/ALVR.US.md) - [IPG.US](https://longbridge.com/en/quote/IPG.US.md) - [AVAV.US](https://longbridge.com/en/quote/AVAV.US.md) - [WMPN.US](https://longbridge.com/en/quote/WMPN.US.md) - [KLRS.US](https://longbridge.com/en/quote/KLRS.US.md) - [INTR.US](https://longbridge.com/en/quote/INTR.US.md) ## Related News & Research - [AeroVironment’s $465 Million Army Laser Win Expands Its Counter-Drone Opportunity](https://longbridge.com/en/news/297928689.md) - [Kalaris Therapeutics management to join Morgan Stanley Global Healthcare Conference fireside chat](https://longbridge.com/en/news/297513633.md) - [Kalaris Therapeutics (NASDAQ:KLRS) Announces Earnings Results](https://longbridge.com/en/news/295542706.md) - [Kalaris Therapeutics Q2 net loss narrows on lower administrative costs](https://longbridge.com/en/news/295534891.md) - [Kalaris Therapeutics director Laurie Keating files initial beneficial ownership statement](https://longbridge.com/en/news/294731013.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**